Steroid use and lipid abnormalities in children: assessing the risk in chronic disease management.
SM, L., M, D., M, Q., & S, I. (2026). Steroid use and lipid abnormalities in children: assessing the risk in chronic disease management.. Folia medica. https://doi.org/10.3897/folmed.68.e171187
SM L, M D, M Q, S I. Steroid use and lipid abnormalities in children: assessing the risk in chronic disease management.. Folia medica. 2026; doi: 10.3897/folmed.68.e171187
SM L, M D, M Q, et al. Steroid use and lipid abnormalities in children: assessing the risk in chronic disease management.[J]. Folia medica. 2026. DOI: 10.3897/folmed.68.e171187.
@article{sm2026,
author = {Lubis SM and Deliana M and Quinka M and Imtiyaz S},
title = {Steroid use and lipid abnormalities in children: assessing the risk in chronic disease management.},
journal = {Folia medica},
year = {2026},
doi = {10.3897/folmed.68.e171187},
note = {PMID: 42677719},
}
TY - JOUR AU - Lubis SM AU - Deliana M AU - Quinka M AU - Imtiyaz S TI - Steroid use and lipid abnormalities in children: assessing the risk in chronic disease management. T2 - Folia medica PY - 2026 DO - 10.3897/folmed.68.e171187 AN - PMID:42677719 ER -
Although steroid-induced dyslipidemia is well-documented in adults, its impact on children remains underexplored. Given the long-term cardiovascular risks associated with dyslipidemia, understanding its link with steroid use in children is crucial.